UBE2V1 (TMEM189-UBE2V1) Human shRNA Plasmid Kit (Locus ID 387522)
CAT#: TL307919
TMEM189-UBE2V1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 7,740.00
Product images
CNY 4,070.00
Specifications
Product Data | |
Product Name | UBE2V1 (TMEM189-UBE2V1) Human shRNA Plasmid Kit (Locus ID 387522) |
Locus ID | 387522 |
UniProt ID | Q13404 |
Synonyms | CROC-1B; Kua; Kua-UEV; OTTHUMP00000031794; transmembrane protein 189; UBE2V1; ubiquitin-conjugating enzyme E2 variant 1; ubiquitin-conjugating enzyme variant Kua |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | TMEM189-UBE2V1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 387522). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_003349, NM_199203, NM_199203.1, NM_199203.2, NM_003349.4, BC172339, BM556348 |
Summary | The TMEM189-UEV mRNA is an infrequent but naturally occurring read-through transcript of the neighboring TMEM189 and UBE2V1 genes. Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein produced by this transcript has UEV1 B domains but the protein is localized to the cytoplasm rather than to the nucleus. The significance of this read-through mRNA and the function of its protein product has not yet been determined. [provided by RefSeq, Oct 2010] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
其它PEDS1-UBE2V1产品